Clostridioides difficile infection increases the need for using biologics in patients with inflammatory bowel diseases: a retrospective long-term study.
Sep 2026· European Journal of Gastroenterology and Hepathology· 0 citations· 29 references
Medicine
TL;DR
Recognizing gastrointestinal infection promptly and integrating infection history into therapeutic decision-making may improve patient outcomes by preventing severe disease progression and guiding timely escalation of therapy.
Abstract
Background
Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is characterized by chronic intestinal inflammation and may be complicated by gastrointestinal infections. Among these, Clostridioides difficile infection (CDI) is relevant because of its association with worse outcomes and increased therapeutic needs. We aimed to evaluate the prevalence of enteric infections during IBD flares and to assess the long-term impact of CDI on disease management and treatment escalation.
Methods
We retrospectively analyzed 102 IBD patients hospitalized for disease flares at a single tertiary care center between January 2020 and September 2024. All patients underwent stool testing for enteric pathogens. Clinical, laboratory, and treatment data were collected at baseline and 12 months.
Results
Gastrointestinal infections were detected in 19% of patients; CDI accounted for 58% of these. At 12 months after gastrointestinal infection, advanced therapy use was more frequent in gastrointestinal infection positive (GI+) patients (63% vs. 43%; P = 0.04). CDI+ patients had a significant increase in biologic use over time. Gastrointestinal infection positivity was independently associated with biologic use at 12 months (odds ratio = 3.5, P = 0.02).
Conclusion
Recognizing gastrointestinal infection promptly and integrating infection history into therapeutic decision-making may improve patient outcomes by preventing severe disease progression and guiding timely escalation of therapy.
BACKGROUND
Clostridioides difficile infection (CDI) is one of the leading causes of healthcare-associated and antibiotic-associated diarrhea and is associated with significant morbidity and mortality. Data regarding the clinical characteristics and outcomes of CDI among noninflammatory bowel disease (non-IBD) patients...
Srinivas Gridhati, Sai Sarath Dasari, S. Shanmughanathan et al.· Annals of African medicine· 0 citations
OBJECTIVES
Children with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection (CDI), which is associated with worse clinical outcomes. We aimed to assess current diagnostic and therapeutic practices for CDI among Italian pediatric IBD centers.
METHODS
A nationwide survey was c...
A. Romanchuk, Matteo Bramuzzo, F. Labriola et al.· Journal of Pediatric Gastroe...· 0 citations
Patients with IBD have an increased risk for Clostridioides difficile infection, and the significance of asymptomatic colonization is poorly understood. Overlapping symptoms often complicate diagnosis, and there is a lack of validated screening methods. Colonic wash aspirates collected during routine colonoscopies may...
J. Allegretti, Alexander D. Carlin, E. McClure et al.· Gut microbes· 0 citations
Clostridioides difficile infection (CDI) is a major cause of infections worldwide and can lead to life-threatening complications and a severe impact on patients’ quality of life (QoL). CDI can affect anyone, but it is generally accepted that those at greatest risk include people receiving antibiotics, of older age, and...
J. Allegretti, E. Dubberke, C. Ferreira et al.· Infectious Disease and Thera...· 0 citations
Elevated CRP was associated with an increased risk of subsequent intestinal resection in CD patients with CDI and may have potential prognostic value, and these findings require prospective external validation.
Min-Hui Zheng, Xiao-Bai Pang, Li Li et al.· Journal of Inflammation Rese...· 0 citations
Background/Aims Aeromonas species are Gram-negative, flagellated bacilli suggested to be associated with inflammatory bowel disease (IBD) flare-ups, but their precise role remains controversial. This retrospective study investigated Aeromonas as an enteropathogen in patients with IBD. Methods This study analyzed patien...
D. Kim, Jiyoung Yoon, Jae-Seok Kim et al.· The Korean journal of gastro...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.